glp-1 molecular structure of [ 3 H]liraglutide (top) and the receptor agonists The unsung heroes of GLP-1

Extra caution is appropriate in patients with active cancer, recent cancer, unexplained masses, unexplained weight loss, pregnancy, breastfeeding, known allergy to peptide products, active infection, immune compromise, significant liver or kidney disease, active inflammatory or autoimmune disease flares, unusual clotting history, uncontrolled cardiovascular disease, use of chemotherapy or immune-modifying biologic therapy, and competitive athletes subject to anti-doping rules

Billington et al, 2013)

Interested in losing 15+ pounds

Mechanism of Action Ipamorelin activates the growth hormone secretagogue receptor type 1a (GHS-R1a), also known as the ghrelin receptor, on pituitary somatotroph cells